Even Mild CKD Elevates Infection Risk, Study Finds

Written By :  Dr Riya Dave
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-08-05 15:30 GMT   |   Update On 2025-08-05 15:30 GMT
Advertisement

Researchers have determined in a new study published in EClinicalMedicine that patients with chronic kidney disease (CKD), even at its earliest stages, have a substantially elevated risk of requiring hospitalization for serious infection. The results concluded that reduced kidney function and increased excretion of albumin in the urine are independently and stepwise related to increased risk of infection, even in individuals with only mildly decreased kidney function. The study was conducted by Junichi I. and colleagues.

In this large, meta-analysis, one of the Chronic Kidney Disease Prognosis Consortium (CKD-PC), data from 47 international cohorts with 1,246,912 participants were combined. The investigators compared estimated glomerular filtration rate using serum creatinine (eGFRcr) and urinary albumin-to-creatinine ratio (ACR) to determine the association of these biomarkers with infection-related hospitalization. Infections were infections of the respiratory, urinary, skin, gastrointestinal, genital, nervous, and cardiovascular tracts, and sepsis. Follow-up information was collected through December 31, 2019.

Advertisement

This analysis employed individual participant data from 1.2 million people in 47 cohorts worldwide, for which their eGFRcr and ACR were measured. Both the markers were analyzed as continuous and categorical markers. Acute infection hospitalization was monitored through discharge diagnostic codes, with follow-up censored in December 2019 or at cohort closure. Cox models of proportional hazards were employed to calculate the hazard ratios (HRs) for risk of infection associated with kidney function and with levels of albuminuria.

Key Findings

  • Of more than 1.2 million participants, 170,864 persons (13.7%) were hospitalized for infections in follow-up.

  • The overall rate of incidence (IR) was 22.0 per 1000 person-years (interquartile interval: 16.2–31.0).

  • Relative to those with eGFRcr 90–104 ml/min/1.73 m² and ACR <10 mg/g:

  • Patients with eGFRcr 60–89 had an HR of 1.09 (95% CI: 1.06–1.13)

  • Individuals with eGFRcr 45–59 had an HR of 1.39 (95% CI: 1.34–1.45)

  • ACR 10–29 mg/g was correlated with an HR of 1.40 (95% CI: 1.33–1.47)

  • ACR 30–299 mg/g had an HR of 1.82 (95% CI: 1.72–1.92)

  • Individuals with extremely high eGFRcr ≥105 ml/min/1.73 m² also had higher infection risk (HR: 1.22; 95% CI: 1.17–1.26)—a surprising result indicating non-linear relations at extreme levels.

  • The highest risk was seen in those with both extremely low eGFRcr (<30 ml/min/1.73 m²) and elevated ACR (≥300 mg/g), with combined HR of 6.27 (95% CI: 5.70–6.90)—more than six times as high as the reference group.

  • These trends were consistent regardless of the type of infection. For instance, HR of lower respiratory tract infections was 1.26 (95% CI: 1.22–1.30) per 15 ml/min/1.73 m² reduction in eGFRcr, and 1.48 (95% CI: 1.44–1.53) per 8-fold rise in ACR.

Risk of infection in CKD patients is significant, and this risk starts early in the progression of kidney impairment. The authors of the study concluded that both worsening kidney function and rising albuminuria are independent, additive predictors of hospitalization with infection. These results necessitate specific infection prevention measures not only in those with severe CKD but also in people in preceding stages of kidney disease.

Reference:

Ishigami, J., Surapaneni, A., Matsushita, K., Coresh, J., Grams, M. E., Ballew, S. H., Sang, Y., Stengel, B., Ärnlöv, J., Bell, S., Carrero, J.-J., Chang, A. R., Ciemins, E. L., Haynes, R., Ix, J., Kotsis, F., Lees, J. S., Pandit, K., Rao, P., … Surapaneni, A. (2025). Estimated glomerular filtration rate, albuminuria, and risk of infection: a collaborative meta-analysis of individual participant data. EClinicalMedicine, 86(103372), 103372. https://doi.org/10.1016/j.eclinm.2025.103372

Tags:    
Article Source : EClinicalMedicine

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News